DR. of the Chinese Academy of Sciences, Dr., Chief Physician, and Doctoral Supervisor. Chair Dr. at Shanghai Jiao Tong University, Dean of the School of Gastroenterology, Shanghai Jiao Tong University School of Medicine
Affiliated HospitalRenji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Director of the Gastroenterology Center of Renji Hospital, Executive President of Renji Anhui Hospital, Director of the Shanghai Institute of Digestive Diseases, Director of the Shanghai Clinical Quality Control Center for Gastroenterology, and Director of the National Health Commission Key Laboratory of Internal Medicine and Gastroenterology. He previously served as Vice President and Director of the Department of Gastroenterology at Renji Hospital for many years. He received his Ph.D. in Gastroenterology from Shanghai Second Medical University in 1996; and conducted postdoctoral research at the University of Chicago from September 1998. He is the incoming Chairman of the Chinese Society of Gastroenterology and a member of the Academic Advisory Committee of the Chinese Academy of Medical Sciences. He has been engaged in the diagnosis, treatment, and prevention of gastrointestinal cancer and its precancerous diseases for over 30 years, achieving numerous innovative results in clinical-translational medicine research on early warning, diagnosis, prevention, and comprehensive treatment of gastrointestinal cancer. This research was the first in the world to discover that elevated levels of Streptococcus constellans or Streptococcus pharyngitis in feces indicate a high-risk group for gastric cancer; it was also the first to demonstrate that traditional drugs such as folic acid, berberine, and statins have preventive effects against gastrointestinal cancer; and it was the first to demonstrate that enterobiota can be used to assess the treatment efficacy and prognosis of colorectal cancer. The researcher has published over 200 papers as the sole corresponding or last corresponding author in journals such as Cell, Cancer Cell, Cell Metab, Nat Microbiol, Lancet Oncol, and Gastroenterology; received two National Science and Technology Progress Awards (Second Class) as the first author; has been an Elsevier Highly Cited Researcher for the past six years and a Clarivate Analytics Highly Cited Researcher for the past two years; and has received the Tan Jiazhen Life Science Award and the National Innovation and Advancement Award, among others.